{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:00:11Z","timestamp":1791295211315,"version":"4.1.0"},"reference-count":85,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T00:00:00Z","timestamp":1697500800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005851","name":"Shahid Beheshti University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005851","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.heliyon.2023.e21154","type":"journal-article","created":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T12:59:23Z","timestamp":1697633963000},"page":"e21154","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Prediction of anti-TNF therapy failure in ulcerative colitis patients by ensemble machine learning: A prospective study"],"prefix":"10.1016","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1598-7640","authenticated-orcid":false,"given":"Mohammad Hossein","family":"Derakhshan Nazari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shabnam","family":"Shahrokh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila","family":"Ghanbari-Maman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samaneh","family":"Maleknia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahsa","family":"Ghorbaninejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7956-9712","authenticated-orcid":false,"given":"Anna","family":"Meyfour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.heliyon.2023.e21154_bib1","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41572-020-0205-x","article-title":"Ulcerative colitis","volume":"6","author":"Kobayashi","year":"2020","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.heliyon.2023.e21154_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103329","article-title":"Evaluation of anti-TNF therapeutic response in patients with inflammatory bowel disease: current and novel biomarkers","volume":"66","author":"Cui","year":"2021","journal-title":"EBioMedicine"},{"issue":"3","key":"10.1016\/j.heliyon.2023.e21154_bib3","doi-asserted-by":"crossref","first-page":"384","DOI":"10.14309\/ajg.0000000000000152","article-title":"ACG clinical guideline: ulcerative colitis in adults","volume":"114","author":"Rubin","year":"2019","journal-title":"Am. J. Gastroenterol."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e21154_bib4","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.gtc.2020.07.005","article-title":"Epidemiology and pathogenesis of ulcerative colitis","volume":"49","author":"Du","year":"2020","journal-title":"Gastroenterol. Clin. N. Am."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e21154_bib5","doi-asserted-by":"crossref","first-page":"874","DOI":"10.14309\/ajg.0000000000000183","article-title":"A Treat-to-target update in ulcerative colitis: a systematic review","volume":"114","author":"Ungaro","year":"2019","journal-title":"Am. J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e21154_bib6","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1093\/ecco-jcc\/jjz131","article-title":"Outcomes and strategies to support a Treat-to-target approach in inflammatory bowel disease: a systematic review","volume":"14","author":"Colombel","year":"2020","journal-title":"J Crohns Colitis"},{"issue":"4","key":"10.1016\/j.heliyon.2023.e21154_bib7","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.dld.2020.09.022","article-title":"Medical therapy versus surgery in moderate-to-severe ulcerative colitis","volume":"53","author":"Fiorino","year":"2021","journal-title":"Dig. Liver Dis."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e21154_bib8","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000506898","article-title":"TNF-alpha blockers in inflammatory bowel diseases: practical recommendations and a user's guide: an update","volume":"101","author":"Vulliemoz","year":"2020","journal-title":"Digestion"},{"issue":"6","key":"10.1016\/j.heliyon.2023.e21154_bib9","first-page":"1297","article-title":"Monocyte and M1 macrophage-induced barrier defect contributes to chronic intestinal inflammation in IBD","volume":"21","author":"Lissner","year":"2015","journal-title":"Inflamm. Bowel Dis."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e21154_bib10","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/MIB.0000000000000202","article-title":"Role for therapeutic drug monitoring during induction therapy with TNF antagonists in IBD: evolution in the definition and management of primary nonresponse","volume":"21","author":"Papamichael","year":"2015","journal-title":"Inflamm. Bowel Dis."},{"issue":"12","key":"10.1016\/j.heliyon.2023.e21154_bib11","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1136\/gut.2009.178665","article-title":"Mucosal gene signatures to predict response to infliximab in patients with ulcerative colitis","volume":"58","author":"Arijs","year":"2009","journal-title":"Gut"},{"issue":"10","key":"10.1016\/j.heliyon.2023.e21154_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics11101902","article-title":"A multi-mRNA prognostic signature for anti-TNF\u03b1 therapy response in patients with inflammatory bowel disease","volume":"11","author":"Sakaram","year":"2021","journal-title":"Diagnostics"},{"key":"10.1016\/j.heliyon.2023.e21154_bib13","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.ebiom.2019.01.027","article-title":"Low TREM1 expression in whole blood predicts anti-TNF response in inflammatory bowel disease","volume":"40","author":"Verstockt","year":"2019","journal-title":"EBioMedicine"},{"issue":"4","key":"10.1016\/j.heliyon.2023.e21154_bib14","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1053\/j.gastro.2018.06.077","article-title":"Gene expression signature for prediction of golimumab response in a phase 2a open-Label Trial of patients with ulcerative colitis","volume":"155","author":"Telesco","year":"2018","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e21154_bib15","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1186\/1471-2105-9-284","article-title":"Methods for evaluating gene expression from Affymetrix microarray datasets","volume":"9","author":"Jiang","year":"2008","journal-title":"BMC Bioinf."},{"issue":"10","key":"10.1016\/j.heliyon.2023.e21154_bib16","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1016\/j.jid.2019.07.682","article-title":"Research Techniques made simple: feature selection for biomarker discovery","volume":"139","author":"Torres","year":"2019","journal-title":"J. Invest. Dermatol."},{"issue":"11","key":"10.1016\/j.heliyon.2023.e21154_bib17","doi-asserted-by":"crossref","first-page":"e7984","DOI":"10.1371\/journal.pone.0007984","article-title":"Mucosal gene expression of antimicrobial peptides in inflammatory bowel disease before and after first infliximab treatment","volume":"4","author":"Arijs","year":"2009","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e21154_bib18","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1136\/gutjnl-2016-312293","article-title":"Effect of vedolizumab (anti-\u03b14\u03b27-integrin) therapy on histological healing and mucosal gene expression in patients with UC","volume":"67","author":"Arijs","year":"2018","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e21154_bib19","article-title":"How to do quantile normalization correctly for gene expression data analyses","volume":"10","author":"Zhao","year":"2020","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e21154_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0017238","article-title":"Removing batch effects in analysis of expression microarray data: an evaluation of six batch adjustment methods","volume":"6","author":"Chen","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.heliyon.2023.e21154_bib21","first-page":"323","article-title":"Centralities based analysis of complex networks","author":"Scardoni","year":"2012","journal-title":"New frontiers in graph theory"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e21154_bib22","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s13075-020-02239-3","article-title":"An integrative Bayesian network approach to highlight key drivers in systemic lupus erythematosus","volume":"22","author":"Maleknia","year":"2020","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.heliyon.2023.e21154_bib23","article-title":"Data integration in genetics and genomics: methods and challenges","volume":"2009","author":"Hamid","year":"2009","journal-title":"Hum. Genom. Proteonomics"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e21154_bib24","doi-asserted-by":"crossref","first-page":"9010","DOI":"10.1038\/s41598-021-88489-w","article-title":"Ulcerative colitis immune cell landscapes and differentially expressed gene signatures determine novel regulators and predict clinical response to biologic therapy","volume":"11","author":"Penrose","year":"2021","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e21154_bib25","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1080\/00365521.2016.1235224","article-title":"Neutrophils in ulcerative colitis: a review of selected biomarkers and their potential therapeutic implications","volume":"52","author":"Muthas","year":"2017","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.heliyon.2023.e21154_bib26","series-title":"Anti-TNF-\u03b1 Therapy Suppresses Proinflammatory Activities of Mucosal Neutrophils in Inflammatory Bowel Disease","author":"Zhang","year":"2018"},{"issue":"4","key":"10.1016\/j.heliyon.2023.e21154_bib27","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.cell.2016.07.006","article-title":"Memory of inflammation in regulatory T cells","volume":"166","author":"van der Veeken","year":"2016","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.heliyon.2023.e21154_bib28","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1038\/ajg.2010.345","article-title":"A multicenter experience with infliximab for ulcerative colitis: outcomes and predictors of response, optimization, colectomy, and hospitalization","volume":"105","author":"Oussalah","year":"2010","journal-title":"Am. J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e21154_bib29","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/ibd.20054","article-title":"Predictors of early response to infliximab in patients with ulcerative colitis","volume":"13","author":"Ferrante","year":"2007","journal-title":"Inflamm. Bowel Dis."},{"issue":"10","key":"10.1016\/j.heliyon.2023.e21154_bib30","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a016295","article-title":"IL-6 in inflammation, immunity, and disease","volume":"6","author":"Tanaka","year":"2014","journal-title":"Cold Spring Harbor Perspect. Biol."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e21154_bib31","doi-asserted-by":"crossref","first-page":"695","DOI":"10.4049\/jimmunol.1403187","article-title":"The importance of IL-6 in the development of LAT-mediated autoimmunity","volume":"195","author":"O'Brien","year":"2015","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e21154_bib32","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.cytogfr.2006.09.003","article-title":"Interleukin-6 trans-signaling in inflammatory bowel disease","volume":"17","author":"Mitsuyama","year":"2006","journal-title":"Cytokine Growth Factor Rev."},{"issue":"5","key":"10.1016\/j.heliyon.2023.e21154_bib33","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1002\/eji.201142327","article-title":"IL-6 promotes immune responses in human ulcerative colitis and induces a skin-homing phenotype in the dendritic cells and Tcells they stimulate","volume":"42","author":"Bernardo","year":"2012","journal-title":"Eur. J. Immunol."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e21154_bib34","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/cbf.3573","article-title":"Inhibin, beta A regulates the transforming growth factor-beta pathway to promote malignant biological behaviour in colorectal cancer","volume":"39","author":"He","year":"2021","journal-title":"Cell Biochem. Funct."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e21154_bib35","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.immuni.2006.07.011","article-title":"Transforming growth factor-beta controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms","volume":"25","author":"Li","year":"2006","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.heliyon.2023.e21154_bib36","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.immuni.2006.07.012","article-title":"Cellular mechanisms of fatal early-onset autoimmunity in mice with the T cell-specific targeting of transforming growth factor-beta receptor","volume":"25","author":"Marie","year":"2006","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.heliyon.2023.e21154_bib37","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.coph.2009.04.008","article-title":"Anti-inflammatory and pro-inflammatory roles of TGF-beta, IL-10, and IL-22 in immunity and autoimmunity","volume":"9","author":"Sanjabi","year":"2009","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.heliyon.2023.e21154_bib38","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1146\/annurev.immunol.021908.132710","article-title":"IL-17 and Th17 cells","volume":"27","author":"Korn","year":"2009","journal-title":"Annu. Rev. Immunol."},{"issue":"9","key":"10.1016\/j.heliyon.2023.e21154_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21093364","article-title":"Gene signatures of early response to anti-TNF drugs in pediatric inflammatory bowel disease","volume":"21","author":"Salvador-Mart\u00edn","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.heliyon.2023.e21154_bib40","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2147\/JIR.S236262","article-title":"Integrated gene expression profiling analysis reveals probable molecular mechanism and candidate biomarker in anti-TNF\u03b1 non-response IBD patients","volume":"13","author":"Liu","year":"2020","journal-title":"J. Inflamm. Res."},{"issue":"12","key":"10.1016\/j.heliyon.2023.e21154_bib41","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1002\/ibd.21301","article-title":"Predictive value of epithelial gene expression profiles for response to infliximab in Crohn's disease","volume":"16","author":"Arijs","year":"2010","journal-title":"Inflamm. Bowel Dis."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e21154_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10040853","article-title":"Predictors and early markers of response to biological therapies in inflammatory bowel diseases","volume":"10","author":"Privitera","year":"2021","journal-title":"J. Clin. Med."},{"issue":"5","key":"10.1016\/j.heliyon.2023.e21154_bib43","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1161\/ATVBAHA.110.207449","article-title":"Prostaglandins and inflammation","volume":"31","author":"Ricciotti","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e21154_bib44","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/sj.bjc.6601906","article-title":"Polymorphisms in prostaglandin synthase 2\/cyclooxygenase 2 (PTGS2\/COX2) and risk of colorectal cancer","volume":"91","author":"Cox","year":"2004","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.heliyon.2023.e21154_bib45","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/1471-230X-11-138","article-title":"Transcript levels of Toll-like receptors 5, 8 and 9 correlate with inflammatory activity in ulcerative colitis","volume":"11","author":"Sanchez-Munoz","year":"2011","journal-title":"BMC Gastroenterol."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e21154_bib46","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/ibd.20754","article-title":"High-frequency haplotypes in the X chromosome locus TLR8 are associated with both CD and UC in females","volume":"15","author":"Saruta","year":"2009","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.heliyon.2023.e21154_bib47","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3389\/fimmu.2018.00072","article-title":"Toll-like receptors and inflammatory bowel disease","volume":"9","author":"Lu","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.heliyon.2023.e21154_bib48","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jaut.2013.06.007","article-title":"Interleukin-7: fuel for the autoimmune attack","volume":"45","author":"Dooms","year":"2013","journal-title":"J. Autoimmun."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e21154_bib49","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.it.2004.11.006","article-title":"The new paradigm of T-cell homeostatic proliferation-induced autoimmunity","volume":"26","author":"Baccala","year":"2005","journal-title":"Trends Immunol."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e21154_bib50","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1471-2172-13-8","article-title":"Age-related accumulation of T cells with markers of relatively stronger autoreactivity leads to functional erosion of T cells","volume":"13","author":"Tatari-Calderone","year":"2012","journal-title":"BMC Immunol."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e21154_bib51","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/1751-2980.12035","article-title":"Label-free quantification for discovering novel biomarkers in the diagnosis and assessment of disease activity in inflammatory bowel disease","volume":"14","author":"Han","year":"2013","journal-title":"J Dig Dis"},{"issue":"4","key":"10.1016\/j.heliyon.2023.e21154_bib52","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jbspin.2014.01.013","article-title":"Gene expression profile predicting the response to anti-TNF treatment in patients with rheumatoid arthritis; analysis of GEO datasets","volume":"81","author":"Kim","year":"2014","journal-title":"Joint Bone Spine"},{"issue":"8","key":"10.1016\/j.heliyon.2023.e21154_bib53","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1182\/bloodadvances.2021006398","article-title":"Lymphocyte cytosolic protein 1 (L-plastin) I232F mutation impairs granulocytic proliferation and causes neutropenia","volume":"6","author":"Mahat","year":"2022","journal-title":"Blood Advances"},{"issue":"15","key":"10.1016\/j.heliyon.2023.e21154_bib54","doi-asserted-by":"crossref","first-page":"7257","DOI":"10.1111\/jcmm.16755","article-title":"Aureusidin derivative CNQX inhibits chronic colitis inflammation and mucosal barrier damage by targeting myeloid differentiation 2 protein","volume":"25","author":"Yang","year":"2021","journal-title":"J. Cell Mol. Med."},{"issue":"8","key":"10.1016\/j.heliyon.2023.e21154_bib55","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.7150\/ijbs.39098","article-title":"Selective targeting of the TLR4 co-receptor, MD2, prevents colon cancer growth and lung metastasis","volume":"16","author":"Rajamanickam","year":"2020","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.heliyon.2023.e21154_bib56","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0065-2776(07)96005-8","article-title":"Fc-receptors as regulators of immunity","volume":"96","author":"Nimmerjahn","year":"2007","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.heliyon.2023.e21154_bib57","doi-asserted-by":"crossref","first-page":"805","DOI":"10.3389\/fimmu.2019.00805","article-title":"IgG and Fc\u03b3 receptors in intestinal immunity and inflammation","volume":"10","author":"Castro-Dopico","year":"2019","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e21154_bib58","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cell.2017.06.009","article-title":"RAS proteins and their regulators in human disease","volume":"170","author":"Simanshu","year":"2017","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.heliyon.2023.e21154_bib59","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nrm2438","article-title":"Ras oncogenes: split personalities","volume":"9","author":"Karnoub","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e21154_bib60","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.cell.2019.03.030","article-title":"Proteogenomic analysis of human colon cancer reveals new therapeutic opportunities","volume":"177","author":"Vasaikar","year":"2019","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.heliyon.2023.e21154_bib61","doi-asserted-by":"crossref","first-page":"e8503","DOI":"10.15252\/msb.20188503","article-title":"A deep proteome and transcriptome abundance atlas of 29 healthy human tissues","volume":"15","author":"Wang","year":"2019","journal-title":"Mol. Syst. Biol."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e21154_bib62","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12964-021-00712-3","article-title":"Signaling pathways in intestinal homeostasis and colorectal cancer: KRAS at centre stage","volume":"19","author":"Ternet","year":"2021","journal-title":"Cell Commun. Signal."},{"issue":"14","key":"10.1016\/j.heliyon.2023.e21154_bib63","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1038\/sj.onc.1209237","article-title":"K-ras activation generates an inflammatory response in lung tumors","volume":"25","author":"Ji","year":"2006","journal-title":"Oncogene"},{"issue":"7","key":"10.1016\/j.heliyon.2023.e21154_bib64","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0898-6568(00)00084-X","article-title":"The importance of being K-Ras","volume":"12","author":"Ellis","year":"2000","journal-title":"Cell. Signal."},{"issue":"5","key":"10.1016\/j.heliyon.2023.e21154_bib65","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00428-008-0665-y","article-title":"KRAS mutation testing for predicting response to anti-EGFR therapy for colorectal carcinoma: proposal for an European quality assurance program","volume":"453","author":"van Krieken","year":"2008","journal-title":"Virchows Arch."},{"issue":"10","key":"10.1016\/j.heliyon.2023.e21154_bib66","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1016\/j.jid.2019.07.682","article-title":"Research Techniques made simple: feature Selection\u00a0for\u00a0Biomarker discovery","volume":"139","author":"Torres","year":"2019","journal-title":"J. Invest. Dermatol."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e21154_bib67","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.yamp.2019.07.010","article-title":"Machine learning in biology and medicine","volume":"2","author":"Noorbakhsh","year":"2019","journal-title":"Advances in Molecular Pathology"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e21154_bib68","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1186\/1471-2105-7-520","article-title":"An accurate and interpretable model for siRNA efficacy prediction","volume":"7","author":"Vert","year":"2006","journal-title":"BMC Bioinf."},{"issue":"5","key":"10.1016\/j.heliyon.2023.e21154_bib69","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/apt.15126","article-title":"Mucosal IL13RA2 expression predicts nonresponse to anti-TNF therapy in Crohn's disease","volume":"49","author":"Verstockt","year":"2019","journal-title":"Aliment Pharmacol. Therapeut."},{"issue":"5","key":"10.1016\/j.heliyon.2023.e21154_bib70","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1038\/s41385-019-0189-6","article-title":"Anti-IL-13R\u03b12 therapy promotes recovery in a murine model of inflammatory bowel disease","volume":"12","author":"Karmele","year":"2019","journal-title":"Mucosal Immunol."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e21154_bib71","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/mi.2015.123","article-title":"The activation of Wnt signaling by a STAT6-dependent macrophage phenotype promotes mucosal repair in murine IBD","volume":"9","author":"Cos\u00edn-Roger","year":"2016","journal-title":"Mucosal Immunol."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e21154_bib72","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.semcdb.2007.07.003","article-title":"Matrix metalloproteinases as modulators of inflammation","volume":"19","author":"Manicone","year":"2008","journal-title":"Semin. Cell Dev. Biol."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e21154_bib73","doi-asserted-by":"crossref","first-page":"212","DOI":"10.4161\/mabs.2.3.11780","article-title":"Cleavage of IgGs by proteases associated with invasive diseases: an evasion tactic against host immunity?","volume":"2","author":"Brezski","year":"2010","journal-title":"mAbs"},{"issue":"6","key":"10.1016\/j.heliyon.2023.e21154_bib74","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1053\/j.gastro.2015.07.002","article-title":"Proteolytic cleavage and Loss of function of biologic agents that neutralize tumor Necrosis factor in the mucosa of patients with inflammatory bowel disease","volume":"149","author":"Biancheri","year":"2015","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.heliyon.2023.e21154_bib75","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1093\/ibd\/izz195","article-title":"Matrix metalloproteinase 3 predicts therapeutic response in inflammatory bowel disease patients treated with infliximab","volume":"26","author":"Barberio","year":"2020","journal-title":"Inflamm. Bowel Dis."},{"issue":"33","key":"10.1016\/j.heliyon.2023.e21154_bib76","doi-asserted-by":"crossref","first-page":"21928","DOI":"10.1074\/jbc.M109.019455","article-title":"Deorphanization of GPR109B as a receptor for the beta-oxidation intermediate 3-OH-octanoic acid and its role in the regulation of lipolysis","volume":"284","author":"Ahmed","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.heliyon.2023.e21154_bib77","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1008145","article-title":"Metabolites of lactic acid bacteria present in fermented foods are highly potent agonists of human hydroxycarboxylic acid receptor 3","volume":"15","author":"Peters","year":"2019","journal-title":"PLoS Genet."},{"key":"10.1016\/j.heliyon.2023.e21154_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.106047","article-title":"Hydroxycarboxylic acid receptor 3 and GPR84 - two metabolite-sensing G protein-coupled receptors with opposing functions in innate immune cells","volume":"176","author":"Peters","year":"2022","journal-title":"Pharmacol. Res."},{"issue":"11","key":"10.1016\/j.heliyon.2023.e21154_bib79","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1248\/bpb.b20-00488","article-title":"Bioinformatics analysis of key candidate genes and pathways in ulcerative colitis","volume":"43","author":"Xu","year":"2020","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.heliyon.2023.e21154_bib80","article-title":"Integrated analysis of multiple microarray studies to identify novel gene signatures in ulcerative colitis","volume":"12","author":"Chen","year":"2021","journal-title":"Front. Genet."},{"issue":"39","key":"10.1016\/j.heliyon.2023.e21154_bib81","doi-asserted-by":"crossref","first-page":"5983","DOI":"10.3748\/wjg.v26.i39.5983","article-title":"Identification of differentially expressed genes in ulcerative colitis and verification in a colitis mouse model by bioinformatics analyses","volume":"26","author":"Shi","year":"2020","journal-title":"World J. Gastroenterol."},{"issue":"7","key":"10.1016\/j.heliyon.2023.e21154_bib82","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/nri2356","article-title":"Colony-stimulating factors in inflammation and autoimmunity","volume":"8","author":"Hamilton","year":"2008","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.heliyon.2023.e21154_bib83","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1182\/blood-2008-04-149575","article-title":"Granulocyte colony-stimulating factor delays neutrophil apoptosis by inhibition of calpains upstream of caspase-3","volume":"112","author":"van Raam","year":"2008","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.heliyon.2023.e21154_bib84","doi-asserted-by":"crossref","first-page":"296","DOI":"10.2174\/157489310794072508","article-title":"A review of ensemble methods in bioinformatics","volume":"5","author":"Yang","year":"2010","journal-title":"Curr. Bioinf."},{"key":"10.1016\/j.heliyon.2023.e21154_bib85","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/478410","article-title":"An efficient ensemble learning method for gene microarray classification","volume":"2013","author":"Osareh","year":"2013","journal-title":"BioMed Res. Int."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023083627?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023083627?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:34:19Z","timestamp":1791293659000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844023083627"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":85,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S2405844023083627"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e21154","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prediction of anti-TNF therapy failure in ulcerative colitis patients by ensemble machine learning: A prospective study","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e21154","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e21154"}}